Eurofins stock edges higher after PDMR share transactions and solid H1 2026 backdrop

Published on 09/15/2026 at 20:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins stock on Euronext Paris traded around EUR 72.68 on September 15, 2026, modestly above the prior close as PDMR share dealings disclosed on September 15, 2026 draw attention. The H1 2026 results published on July 23, 2026 provide the fundamental backdrop for the current valuation.

Wissenschaftlerin analysiert Lebensmittelproben mit Pipette im modernen Testlabor — Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Eurofins Scientific SE stock (ISIN FR0014000MR3) was quoted at EUR 72.68 on Euronext Paris in the afternoon of September 15, 2026, representing a gain of 0.72 percent versus the previous close of EUR 72.16 and signaling a steady upward bias after recent sessions.

Eurofins stock reacts to PDMR share dealings

Investor attention on September 15, 2026 is shaped by fresh disclosures of dealings by Persons Discharging Managerial Responsibilities (PDMR) in Eurofins shares, published in a Director/PDMR Shareholding notice.Business Wire reports that one transaction on September 11, 2026 involved the sale of 500 Eurofins shares at a price of EUR 71.34 per share on Euronext Paris, corresponding to aggregated proceeds of EUR 35,670.00 for that specific line.

In the same filing, Business Wire highlights that on September 14, 2026 a PDMR exercised 1,400 stock options under the Eurofins stock option program, including one line of 700 shares at an exercise price of EUR 32.50, which generated an aggregated amount of EUR 22,750.00 for that portion of the exercise.

Price level and short-term performance

Per a real-time analyst and market overview, Eurofins stock traded at EUR 72.68 on Euronext Paris at 3:34 p.m. Central European Daylight Time on September 15, 2026, up EUR 0.52 or 0.72 percent from the previous close of EUR 72.16, with the session open marked at EUR 72.18.Barrons lists the same intraday snapshot for the ERF ticker.

Recent trading history illustrates that Eurofins shares had closed at EUR 71.20 on September 8, 2026 and at EUR 70.94 on September 9, 2026, with the latter representing a daily decline of 0.37 percent on volume of 413,214 shares.MarketScreener identifies EUR 71.20 as the last recorded closing price prior to that sequence, underscoring that the current EUR 72.68 level stands modestly above these recent closes.

H1 2026 results underpin the valuation

Eurofins has emphasized that its half-year 2026 results were published on July 23, 2026, providing investors with the most recent comprehensive view of revenue, profit and margins.Eurofins states that the H1 2026 report, covering the six months ended June 30, 2026, is the latest set of interim figures and thus forms the fundamental backdrop for the current share price as of September 15, 2026.

While the detailed H1 2026 income statement and balance sheet are set out in the full report, the timing of the publication within the permitted recency window means these half-year figures qualify as the key current fundamentals leading up to mid-September 2026. For investors, the combination of PDMR option exercises at EUR 32.50 and market trades around EUR 72.68 highlights the gap between historical grant prices and today’s valuation, offering a concrete numerical comparison that underlines the long-term appreciation of the stock since those options were issued.

Stock positioning for investors

From a practical trading perspective, Eurofins Scientific SE shares are listed on Euronext Paris under the ERF ticker, with the price of EUR 72.68 as of 3:34 p.m. CEDT on September 15, 2026 serving as the primary reference for the stock in euros.Barrons presents this quote alongside broader index data.